Best pharma stocks in India Yesterday, I was reading the second part of Amish Tripathi's famous Shiva Trilogy - The Oath of The Vayputras. The immediate companies to benefit from the increasing demand for these medicines are IOL Chemicals and Granules India. For the financial year 2021-22, the company earned a total revenue of Rs 37,649 million (m) out of which around 38 per cent of sales came from selling paracetamol. Even if covid-19 outbreak stays confined to China, these companies will easily benefit from the outbreak because of their huge market share. Investment Takeaway Investors should keep in mind that these stocks are rallying because of market expectations.